Plain-English translation of NCT07229313 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This study is testing a new cancer medication called to see if it is safe and effective for people with advanced solid tumors that have stopped responding to standard treatments. The trial has two parts: first, researchers will gradually increase doses of the medication to find the safest amount that works, and then they will give that dose to more patients to confirm it is tolerable.
Many people with advanced cancers run out of treatment options when their cancer becomes resistant to standard therapies. This trial exists to test whether this new medication could offer hope for patients who have exhausted other available treatments.
You likely qualify if…
You likely don't qualify if…
In Part A (dose-finding), you will receive the medication at gradually increasing doses to determine the safest effective dose. In Part B (dose-expansion), you will receive the safe dose identified in Part A. You will have regular clinic visits for blood tests, scans, and check-ins with the research team to monitor how you respond to the treatment and track any side effects.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
United States
Australia